These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26915718)
1. Prevalence of rosacea in the general population of Germany and Russia - The RISE study. Tan J; Schöfer H; Araviiskaia E; Audibert F; Kerrouche N; Berg M; J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):428-34. PubMed ID: 26915718 [TBL] [Abstract][Full Text] [Related]
2. Measurement of Disease Severity in a Population of Rosacea Patients. Alinia H; Tuchayi SM; James SM; Cardwell LA; Nanda S; Bahrami N; Awosika O; Richardson I; Huang KE; Feldman SR Dermatol Clin; 2018 Apr; 36(2):97-102. PubMed ID: 29499805 [TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of a Rosacea Screening Instrument (Rosascreen). Tan J; Leyden J; Cribier B; Audibert F; Kerrouche N; Berg M; J Cutan Med Surg; 2016 Jul; 20(4):317-22. PubMed ID: 26834119 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of rosacea in an Estonian working population using a standard classification. Abram K; Silm H; Oona M Acta Derm Venereol; 2010 May; 90(3):269-73. PubMed ID: 20526544 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of primary headache disorders in Russia: a countrywide survey. Ayzenberg I; Katsarava Z; Sborowski A; Chernysh M; Osipova V; Tabeeva G; Yakhno N; Steiner TJ; Cephalalgia; 2012 Apr; 32(5):373-81. PubMed ID: 22395797 [TBL] [Abstract][Full Text] [Related]
6. A study on the epidemiology of rosacea in the U.K. Spoendlin J; Voegel JJ; Jick SS; Meier CR Br J Dermatol; 2012 Sep; 167(3):598-605. PubMed ID: 22564022 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of rosacea: updated data]. Chosidow O; Cribier B Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S124-8. PubMed ID: 21907871 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of rosacea: updated data. Chosidow O; Cribier B Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S179-83. PubMed ID: 22183096 [TBL] [Abstract][Full Text] [Related]
9. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom. Spoendlin J; Voegel JJ; Jick SS; Meier CR J Am Acad Dermatol; 2013 Sep; 69(3):399-406. PubMed ID: 23643255 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of rosacea in community settings. Moustafa F; Hopkinson D; Huang KE; Feldman S J Cutan Med Surg; 2015; 19(2):149-52. PubMed ID: 25775639 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological and clinical features of rosacea in Korea: A multicenter cross-sectional study. Lee JB; Moon J; Moon KR; Yang JH; Kye YC; Kim KJ; Kim NI; Ro YS; Park KY; Park MY; Song M; Ahn KJ; Ahn HH; Lee MW; Lee WJ; Choi YS; Choi YW; Kwon HH; Suh DH J Dermatol; 2018 May; 45(5):546-553. PubMed ID: 29574999 [TBL] [Abstract][Full Text] [Related]
12. Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity. Harper J; Del Rosso JQ; Ferrusi IL J Drugs Dermatol; 2018 Feb; 17(2):150-158. PubMed ID: 29462222 [TBL] [Abstract][Full Text] [Related]
13. Facial skin complaints and work at visual display units. Epidemiological, clinical and histopathological studies. Berg M Acta Derm Venereol Suppl (Stockh); 1989; 150():1-40. PubMed ID: 2533443 [TBL] [Abstract][Full Text] [Related]
14. [Quality of life in patients with rosacea]. Salamon M; Chodkiewicz J; Sysa-Jedrzejowska A; Wozniacka A Przegl Lek; 2008; 65(9):385-9. PubMed ID: 19140386 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive epidemiological study of rosacea in Germany. Zierl S; Guertler A; Hildebrand JA; Clanner-Engelshofen BM; French LE; Reinholz M Eur J Dermatol; 2021 Dec; 31(6):744-751. PubMed ID: 34935620 [TBL] [Abstract][Full Text] [Related]
17. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. Rainer BM; Fischer AH; Luz Felipe da Silva D; Kang S; Chien AL J Am Acad Dermatol; 2015 Oct; 73(4):604-8. PubMed ID: 26256428 [TBL] [Abstract][Full Text] [Related]